menu
    • menu

    Company profile for Rakovina Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Rakovina Therapeutics, Inc. was founded in 2020 with a vision to transform and extend the lives of patients with cancer. Our team has deep experience in drug discovery research, preclinical and clinical development and regulatory affairs necessary to advance breakthrough innovations to become potential life-changing treatments in the oncology field. Our approach centers on using groundbreaking science to create new preci...
    Rakovina Therapeutics, Inc. was founded in 2020 with a vision to transform and extend the lives of patients with cancer. Our team has deep experience in drug discovery research, preclinical and clinical development and regulatory affairs necessary to advance breakthrough innovations to become potential life-changing treatments in the oncology field. Our approach centers on using groundbreaking science to create new precision medicines targeting critical DNA damage repair pathway mutations that are the hallmarks of many cancers. We are committed to conducting innovative cutting-edge research with the aim of benefiting patients worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rakovina TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Suite 2201 – 8 Smithe Mews Vancouver, British Columbia
    Telephone
    Telephone
    1-604-619-0225
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rakovinatherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rakovina Therapeutics: Q3 2025 Results and Corporate Update
    Rakovina Therapeutics: Q3 2025 Results and Corporate Update

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196721/0/en/Rakovina-Therapeutics-Announces-Three-Month-Q3-ended-September-30-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Rakovina Therapeutics Extends Debentures With Debentureholder
    Rakovina Therapeutics Extends Debentures With Debentureholder

    28 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/29/3196493/0/en/Rakovina-Therapeutics-Announces-Debentureholder-Approval-of-Debenture-Extension-Expiry-of-Warrant-Incentive-Program.html

    GLOBENEWSWIRE
    28 Nov 2025
    Share Share
    Rakovina Therapeutics Presents 2nd Abstract at SNO 2025
    Rakovina Therapeutics Presents 2nd Abstract at SNO 2025

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193315/0/en/Rakovina-Therapeutics-Inc-Announces-Presentation-of-Second-Abstract-at-the-2025-Society-for-Neuro-Oncology-Annual-Meeting.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Rakovina Presents Preclinical Data On CNS ATR mTOR Inhibitors
    Rakovina Presents Preclinical Data On CNS ATR mTOR Inhibitors

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193233/0/en/Rakovina-Therapeutics-Showcases-Compelling-Preclinical-Data-on-AI-Discovered-CNS-Penetrant-ATR-mTOR-Inhibitors-at-the-2025-Society-for-Neuro-Oncology-Annual-Meeting.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Rakovina President To Join Expert Panel At DDR Summit
    Rakovina President To Join Expert Panel At DDR Summit

    18 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/18/3189736/0/en/Rakovina-Therapeutics-President-CSO-to-Present-and-Join-Expert-Panel-at-the-9th-Annual-DDR-Inhibitors-Summit.html

    GLOBENEWSWIRE
    18 Nov 2025
    Share Share
    Rakovina Showcases CNS-Penetrant ATR & PARP1 Inhibitors
    Rakovina Showcases CNS-Penetrant ATR & PARP1 Inhibitors

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184929/0/en/Rakovina-Therapeutics-to-Present-New-Data-Highlighting-CNS-Penetrant-ATR-and-PARP1-Inhibitors-at-the-2025-Society-for-Neuro-Oncology-Annual-Meeting.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search